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Measurement Properties of the Brief Pain Inventory-
Short Form (BPI-SF) and the Revised Short McGill 
Pain Questionnaire-Version-2 (SF-MPQ-2) in Pain-
related Musculoskeletal Conditions: A Systematic 
Review Protocol
Abstract
Background: The Brief Pain Inventory-Short Form (BPI-SF) and Revised Short-Form McGill Pain Questionnaire Version-2 
(SF-MPQ-2) are generic pain assessment tools used in research and practice for pain assessment in musculoskeletal 
(MSK) conditions. A comprehensive review that systematically analyses their measurement properties in MSK conditions 
has not been performed. This review protocol describes the steps that will be taken to locate, critically appraise, compare 
and summarize clinical measurement research on the BPI-SF and SF-MPQ-2 in pain-related MSK conditions. 
Methods: Medline, EMBASE, CINAHL and Scopus will be searched for publications that examine the measurement 
properties of the Brief Pain Inventory and Revised Short-Form McGill Pain Questionnaire Version-2. Two reviewers 
will independently screen citations (title, abstract and full text) and extract relevant data. The extensiveness, rigor, 
and quality of measurement property reports will be examined with a structured measurement studies appraisal tool, 
and with the updated COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) 
guidelines. Findings will be descriptively summarized, and when possible, a meta-analysis will be performed. 
Discussion: This review will summarize and compare the current level of evidence on the measurement properties of the 
BPI-SF and SF-MPQ-2 in a spectrum of musculoskeletal conditions. We expect clinicians/researchers dealing with MSK 
conditions to have synthesized evidence that informs their decision making and preferences. In addition, the review hopes 
to identify gaps and determine priorities for future research with or on the BPI-SF and SF-MPQ-2 in MSK conditions.  
   
Level of evidence: Not Applicable 
Keywords: Brief pain inventory, McGill pain questionnaire, Musculoskeletal conditions, Patient reported outcomes, 
Psychometrics properties, Systematic review
Introduction
Musculoskeletal (MSK) conditions are a major cause of long-term pain and disability (1,2). Pain resulting from MSK conditions has a significant impact on patients general quality of life and is one of the most common reasons people seek medical attention (3). Although acute and ongoing pain 
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quality assessment tool and the COSMIN guidelines will 
be used to evaluate, synthesize and compare the quality 
of measurement research available on the BPI-SF and 
SF-MPQ-2 in MSK conditions before a meta-analysis will 
be pursued.
Data Source and Search Strategy
The following bibliographic databases will be searched 
to identify relevant citations: Medline—OVID (1946 
to 2018); EMBASE—OVID (1947 to 2018); CINAHL—
Cumulative Index to Nursing and Allied Health Literature 
(1937 to 2018); Scopus (1995 to 2018). Grey literature 
will not be searched. We have developed and piloted 
our search strategies in consultation with a health-
research Librarian (see Appendix 1 for the detailed 
search expressions). The search strategies combine 
terms representing the name of both tools i.e. Brief Pain 
Inventory and McGill Pain Questionnaire, with terms 
representing the concepts of measurement properties 
including validity, reliability, and responsiveness. The 
terms for measurement properties were refined from the 
search-filter validated by Terwee et al. (18); the search 
strategy has been successfully piloted in the CINAHL 
database (see Table 1 for the piloted search results). 
All our searches will be adapted to fit the uniqueness 
of the four bibliographic databases. The search for BPI-
SF articles will not be restricted by time or language; 
however, the search for SF-MPQ-2 will be restricted to 
its first publication date (i.e. January 1st, 2009) to avoid 
retrieving undesired articles on its parent versions (SF-
MPQ and MPQ) (6).
Eligibility requirements
Inclusion Criteria
We will include studies that evaluated any of the 
measurement properties of the BPI-SF and SF-MPQ-2 in 
sample populations of adults (16 years of age or greater) 
where at least 70% of participants had MSK conditions. 
There will be no language restriction. 
Exclusion Criteria
We will exclude: (a) all conference presentations 
(with no link to the full article), editorials including 
short clinical communications and commentaries, 
clinical trial protocols, and individual case reports; 
(b) studies that reported pain from other populations 
other than MSK populations. Examples are studies 
with unclear terms describing  participants’ pain, 
such as: ‘non-malignant pain’, ‘chronic pain’ and 
‘non-cancer pain’, without relating such pain to be of 
MSK origin fully or partly; (c) studies that reported 
pain from individuals living with disability (e.g. 
congenital and developmental abnormalities); (d) 
studies that reported pain from individuals suffering 
from neoplasm, infections, surgical procedures 
not due to MSK conditions (e.g. coronary heart 
surgery, laparotomy), neurological or neuropathic 
conditions (not described as fibromyalgia or complex 
regional pain syndrome, or lumbar/cervical/thoracic 
radiculopathies coexisting in MSK conditions like neck 
pain, or back pain), and  HIV AIDs pain.
have traditionally been hard to understand, patient-
reported outcome measures (PROMs) have been useful 
for assessing and monitoring pain experiences (1,2). 
Generally, PROMs can be disease-specific or generic. 
Disease-specific PROMs were developed to assess the 
impact of a specific condition on the patient while 
generic PROMs are applicable to multiple conditions, 
and capture how illness impacts several constructs 
including pain and quality of life (4). The Brief Pain 
Inventory-Short Form (BPI-SF) and the Revised Short-
form McGill Pain Questionnaire Version-2 (SF-MPQ-2), 
are examples of multidimensional pain assessment 
tools that were originally developed or tested in specific 
disease populations but now are commonly used for 
pain assessment in musculoskeletal conditions (5-7). 
While the BPI-SF captures the severity and interference 
of pain with daily functioning, the SF-MPQ-2 evaluates 
the qualities of neuropathic and nociceptive pain (6, 8).
Generic pain assessment PROMs are assumed useful 
for multiple conditions but were mostly developed from 
assessments conducted in specific conditions, hence a 
need to inspect the evidence backing their use in some 
context (9, 10). Although there is evidence of testing 
the measurement properties of BPI-SF and SF-MPQ-2 
in different conditions other than the populations 
they were originally designed for, there are no studies 
that has systematically evaluated the performance of 
either tool in MSK conditions. Previous reviews that 
examined the BPI-SF and SF-MPQ-2 only summarized 
the PROMs’ measurement properties in low back 
pain MSK conditions (11, 12). Hence, clinicians’ and 
researchers’ decisions on the use of either the BPI-SF 
or SF-MPQ-2 in other MSK conditions are based on the 
suggestions contained in single studies. Therefore, a 
systematic synthesis that includes a quality appraisal of 
evidence on the measurement properties of BPI-SF and 
SF-MPQ-2 will provide helpful information for decision 
making on the use of the tools when studying other MSK 
conditions (13–16). 
This systematic review protocol is important because it 
serves as guide for conducting the review. The purpose of 
this comprehensive review protocol is to explain the steps 
that will be taken to systematically locate, summarize, 
critically appraise and compare measurement research 
utilizing the Brief Pain Inventory-Short Form (BPI-
SF) and the Revised Short McGill Pain Questionnaire 
Version-2 (SF-MPQ-2) in pain-related musculoskeletal 
conditions. 
Materials and Methods
Design
The protocol for this review has been registered 
with Prospero (CRD 42018095862). The review will 
be reported using the Preferred Reporting Items for 
Systematic Review and Meta-Analyses Protocol statement 
and checklist (17). In brief, the review will be conducted 
in four steps: (i) multiple bibliographic databases will be 
searched to identify relevant citations; (ii) title, abstract 
and full-text screenings will be conducted based on pre-
determined eligibility requirements; (iii) all relevant data 
will be extracted; (iv) a structured measurement studies 
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Study selection and screening
We will export the retrieved citations from each of 
the bibliographic database to Covidence systematic 
review management software (© 2017 Covidence) 
for de-duplication and independent study selection. 
Two review authors will independently conduct the 
title and full article screening based on the eligibility 
requirements. A hand-search of the reference list of 
articles emerging from the full-text review will be 
conducted. Disagreements between the screening 
authors will be arbitrated by a third reviewer to 
determine publication eligibility. Furthermore, authors 
of studies will be reached through a maximum of three 
e-mail attempts to clarify issues on the selection of a 
study when a decision is difficult to reach by the three 
review authors, perhaps due to the unclear description 
of study participants MSK conditions. 
Data extraction
A structured data-extraction form will be developed 
from the guide available in the second review author’s 
previous work [JCM] (15). Two review authors will 
work independently to extract data from the included 
studies with a third review author available to resolve 
disagreements.
Data items
We will extract data on several measurement properties 
including floor-ceiling effect, construct validity (criterion-
convergent and known group), internal structure (internal 
consistency and structural validity [i.e. Rasch and factor 
analysis]), reliability (test-retest), responsiveness (Area 
Under the Curve (AUC), change correlation indices, 
standardized response mean [SRM], effect-size [ES]), 
interpretability properties (clinically important difference 
[CID], minimal clinical important difference [MCID]), 
measurement error indices, measurement invariance/
cross-cultural validities. Data will be summarized 
according to the subscale of the tools evaluated, and the 
MSK populations they represent, as follows: 
a) “Mixed” studies that satisfy the requirements 
of  ≥70-percent sample size proportion representing 
MSK conditions, but of different mechanism or 
pathophysiology or described by different body regions. 
b) “Specific” studies conducted among homogenous 
MSK samples described by the body region affected or 
Table 1. Result of pilot search obtained from CINAHL on BPI-SF and SF-MPQ-2
Search 
ID# Search Terms Search Options
Actions 
(results)
S1 (MM “McGill Pain Questionnaire”) OR “mcgill pain questionnaire” Boolean/Phrase (1,575)
S2 (MH “Brief Pain Inventory”) OR “brief pain inventory” Boolean/Phrase (1,119)
S3 (MM “Psychometrics”) OR “psychometric properties” Boolean/Phrase (7,576)
S4 “measurement properties” OR (MM “Outcome Assessment”) OR (MH “Measurement Error+”) Boolean/Phrase (9,048)
S5 (MH “Instrument Validation”) OR (MH “Validation Studies”) OR “validation” Boolean/Phrase (65,782)
S6 “adaptation” Boolean/Phrase (30,104)
S7 “cross cultural” Boolean/Phrase (3,410)
S8
(MH “Reliability and Validity+”) OR “reliability and validity” OR (MH “Predictive Validity”) OR 
(MH “Internal Validity”) OR (MH “Discriminant Validity”) OR (MH “Criterion-Related Valid-
ity+”) OR (MH “Consensual Validity”) OR (MH “Concurrent Validity”)
Boolean/Phrase (149,777)
S9 (MM “Internal Consistency”) OR “internal consistency” Boolean/Phrase (18,784)
S10 (MH “Sensitivity and Specificity”) OR “sensitivity and specificity” OR (MH “ROC Curve”) Boolean/Phrase (47,025)
S11 (MH “Discriminant Analysis”) OR (MH “Discriminant Validity”) Boolean/Phrase (4,634)
S12 (MH “Factor Analysis”) OR “factor analysis” Boolean/Phrase (25,470)
S13 “clinically important difference” Boolean/Phrase (556)
S14 “minimal clinically important difference” Boolean/Phrase (323)
S15 (MH “Rasch Analysis”) OR “rasch analysis” Boolean/Phrase (1,348)
S16 S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 Boolean/Phrase (241,727)
S17 S1 AND S16 Limiters - Published Date: 20090101-20181231 (133)
S18 S2 AND S16 Boolean/Phrase (313)
S17 (n = 133) = Total citations identified for screening on SF-MPQ-2
S18 (n = 313) = Total citations identified for screening on BPI-SF
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the pathophysiology/mechanism. 
There is a tendency for some measurement properties 
to be evaluated in subgroups of a parent ‘Mixed’ sample. 
In such cases, we will extract subgroup reports as 
stand-alone studies and report them as representing 
the relevant MSK condition identified in the study. Our 
grouping is flexible and depends on the characteristics of 
the MSK sample encountered in the included studies. 
Other information to be extracted includes: (a) the 
characteristics of the studies, (e.g. country, language, 
study design, study setting, sample size, the SF-MPQ-2 
and BPI-SF version/subscale/item used), and (b) 
participants characteristics including age and sex. 
To avoid missing important details, as previously 
mentioned, extraction will be conducted in pairs, and the 
result will be compared. We will track articles using the 
standardized data extraction form.
Review Team’s Hypotheses
As recommended by the COSMIN initiative, the 
following hypotheses have been developed to guide the 
quality assessment of measurement properties for this 
review (13, 14):
a) We expect correlations between the two 
questionnaires and other pain/health-related outcome 
tools to be 0.3 and above in magnitude. Correlations will 
be classified as low-to-moderate at 0.3-0.69, and “high” at 
0.7 and above (15, 16).
b) We expect reports on AUC to be ≥ 0.7 to represent 
discrimination beyond chance alone.
c) We expect the correlation of the two questionnaires 
change scores and other pain/health-related outcome 
measures to be ≥ 0.3 rho in magnitude, to be considered 
significant. 
We are, however, unable to define hypotheses to assess 
responsiveness based on the standardized response 
mean (SRM) or effect size (ES) because these are context-
specific indices that depend on several factors including 
the interventions used in the studies. We expect authors 
to provide clear hypotheses that define the magnitude of 
expected change in their studies when these indices for 
responsiveness are reported.
Critical Appraisal of Included Studies
The critical appraisal will be conducted in two phases 
to check the adequacy and breadth of authors reports 
and to assess the risk of bias accompanying reported 
measurement properties. Both phases of appraisal are 
complementary and allow the clinician/researcher to 
gauge the quality of evidence supporting both tools 
in MSK conditions. The first phase addresses issues 
related to the sufficiency of measurement evidence 
reports. The second phase of appraisal examines the 
risk of bias inherent with reports because a study at 
high risk to bias presents undependable evidence 
which requires further investigation, regardless of the 
sufficiency of reports.   
Phase 1: Quality of Measurement Property Reports
 Two review authors will appraise the breadth and 
quality of reports supporting evidence contained in 
each article with the structured clinical measurement 
appraisal tool (see Table 2 and 3 for the tool’s detailed 
description) (19). The tool has previously been shown 
to be highly reliable in evaluating the quality of clinical 
measurement studies, including musculoskeletal 
outcome measures (16, 20). The tool evaluates the 
extent to which a study complies with the following 
criteria: 1) thorough literature review to define the 
research question; 2) specific inclusion/exclusion 
criteria; 3) specific hypotheses; 4) appropriate scope 
of psychometric properties; 5) sample size; 6) follow-
up; 7) the authors referenced specific procedures for 
administration, scoring, and interpretation of procedures; 
8) measurement techniques were standardized; 9) data 
were presented for each hypothesis; 10) appropriate 
Use this form to rate the quality of a clinical measurement study. To decide which score to provide for each item on your quality checklist, pick the 
descriptor that sounds most like what was reported in the study you are evaluating.  Items rank descriptors are provided in the guide. (Forms and 
guides to extract study data for evidence synthesis are available from developer at macderj@mcmaster.ca)
Table 2. Quality Appraisal for Clinical Measurement Research Reports Evaluation Form
Evaluation criteria Score
Study question 2 1 0
1. Was the relevant background work cited to define what is currently known about the measurement properties of measures 
under study, and the potential contributions of the current research question to informing that knowledge base?
Study Design
2. Were appropriate inclusion/exclusion criteria defined?
3. Were specific clinical measurement questions/hypotheses identified?
4. Was an appropriate scope of measurement properties considered?
5. Was an appropriate sample size used?
6. Was appropriate retention/follow-up obtained? (for studies involving retesting; otherwise  n/a)
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To decide which score to provide for each item on your quality checklist, read the following descriptors. Pick the descriptor that sounds most 
like the study you were evaluating with respect to a given item. If there is no documentation about any specific aspect of an item; then you must 
evaluate assuming that it was not done. Given the diversity in clinical measurement properties and design options, the evaluator has to make 
judgments using the criteria below and extend the principles to specific aspects that may not be covered in these brief exemplars.  In many 
cases, the study will not look exactly like the descriptor so there will be some interpretation as to which level of optimal methods for clinical 
measurement studies have been achieved.  In such cases, the evaluator can use the general approach that if this study research design and 
conduct is consistent with best practice (score=2); is acceptable but suboptimal (score=1); is not done/documented, substantially inadequate 
or inappropriate (score=0).
Table 3. Quality Appraisal of a Clinical Measurement Study Interpretation Guide
Descriptors
Study question
Score
1
2
The authors:
- performed a thorough literature review indicating what is currently known, and not known, about the clinical measurement 
properties of the instruments or tests under study  
- presented a critical, and unbiased view of what is known about the current measurement properties
- indicated how the current research question fills a gap in the current knowledge base
- established a research question based on the above.
1 All of the above criteria were not fulfilled, but a sound rationale was provided for the research question.
0 A foundation for the current research question was not clear; and the rationale was not founded on previous literature.
Study design
2
2 Specific inclusion/exclusion criteria for the study were defined, that described the patients enrolled. The subjects were described in terms of health condition/demographics, key relevant outcome mediators and the recruitment context (setting). 
1 Some information on participants and place is provided (not all of above). For example, age/sex/diagnosis and the name or type of the practice is listed; but no additional information. 
0 No information on type of clinical settings or study participants is provided (other than number/mean age). 
Table 2. Continued
Measurements
7. Were specific descriptions provided of the measure under study and the method(s) used to administer it?
8.  Were standardized procedures used to administer all study measures in a manner that minimized potential sources of error/
bias (including the study measure and its comparators)? 
Analyses
9. Were analyses conducted for each specific hypothesis or purpose?
10. Were appropriate statistical tests performed to obtain point estimates of the measurement properties?
11. Were appropriate ancillary analyses done to quantify the confidence in the estimates of the clinical measurement property 
(Precision/Confidence intervals; benchmark comparisons/ROC curves, alternate forms of analysis like SEM/MID, etc.)?
Recommendations
12. Were clear, specific and accurate conclusions made about the clinical measurement properties; that were associated with 
appropriate clinical measurement recommendations and supported by the study objectives, analysis and results?
Subtotals (of columns 1 and 2)
Total score (sum of subtotals/24*100); 
if for a specific paper or topic an item is deemed inappropriate then you can sum of items/2*number of items *100 
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Table 3. Continued
3
2
Specific hypotheses or research questions are provided. The stated study purpose provides specific research questions or hypotheses 
that indicate which specific measurement properties will be evaluated. This should include the specific type of reliability (intra/
inter-rater or test-retest) being tested or the type of validity (construct/criterion/content; longitudinal/concurrent; convergent/
divergent) being tested. A prior hypothesis should describe the level of reliability expected; and for validity, expected relationships 
(strength of associations) or constructs.
1
The types of reliability and validity being tested were apparent in the methods/title, but clear and specific research questions or 
hypotheses were not specified.
0
Specific types of reliability or validity under evaluation were not clearly defined nor were specific hypotheses on reliability and 
validity stated. (“The purpose of this study was to investigate the reliability and validity of…” can be rated as zero if no further detail 
on the types of reliability and validity or the nature of specific hypotheses is stated).
4
2
An appropriate scope of clinical measurement properties would be indicated by
1. A detailed focus on reliability that included multiple forms of reliability (at least two of – intra-rater, inter-rater, test retest); as 
well as both relative and absolute reliability (e.g., ICCs and SEM/MID or limits of agreement)
2. A detailed focus on validity that included multiple forms of validity (content (judgmental); structured (e.g., expert review/survey, 
qualitative interviews, ICF linking) or structural (e.g., factor analyses or Rasch), construct (known group differences; convergent/
divergent associations), criterion (concurrent/predictive), responsiveness; predictive, evaluative or discriminative properties were 
established
3. Three or more indicators of reliability and validity were examined concurrently and provide a rich view on measurement 
properties. 
1 Two or more clinical measurement properties were evaluated, however, scope was narrow and did not meet above criteria. (e.g., internal consistency and one other indicator of validity or reliability ).
0 The scope of clinical measurement properties was very narrow as indicated by a narrow evaluation of only one form of reliability or validity.
5
2 Authors performed a sample size calculation and obtained their recruitment targets. Post-doc power analyses and/or confidence intervals confirm that the sample size was sufficient to define relatively precise estimates of reliability or validity.
1 The authors provide an acceptable rationale for the number of subjects included in the study, but did not present specific sample size calculations or post-doc power analyses (or had a sample  >100 but no justification).
0 Size of the sample was not rationalized or is clearly underpowered.
6
2 90% or more of the patients enrolled for study were re-evaluated. 
1 70% or more of the enrolled patients were re-evaluated.
0 Less than 70% of the patients enrolled in the study were re-evaluated
Measurements
7
2
Documentation is provided for how the studied test is performed.  This includes adequate description of the measure/test and how 
it is administered or scored. The authors may provide or reference a published manual/article that outlines specific procedures for 
administration, scoring (including scoring algorithms, handling of missing data) and interpretation that included any necessary 
information about positioning/active participation of the client, any special equipment required, calibration of equipment if 
necessary, training required, cost, examiner procedures/actions. If no manual is available, then the text describes key details of 
procedures in sufficient detail so they could be replicated.
1 The test(s) and its administration procedures are referenced; but there is inadequate description of the test procedures.
0 Minimal description of test procedures without appropriate references.
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Table 3. Continued
8
2
This item addresses the overall study procedures for administering all study measures (study measure and its comparators) in an 
unbiased way. Test procedures should not introduce systematic errors in the estimation of the clinical measurement properties. 
This includes standardized procedures for who completed or administered the measures. For self-report, this includes order of 
presentation, who completed at what time interval; handling of missing items. If relevant, then the paper should include how 
cultural literacy issues were handled (e.g., exclusion, assisted or surrogate completion). For impairment measures, procedures 
would include calibration of any equipment; use of consistent measurement tools and scoring, a priori exclusion of any participants 
likely to give invalid results/unable to complete testing (not exclusion of after enrollment); use of standardized instructions and 
test procedures.  This can include order of administration of test and quality checking of scores.  For reliability testing, the 
appropriate retest interval will depend on the nature of the condition; but for acute conditions it may require retesting within 
48 hours; whereas chronic/stable conditions are commonly retested within 4-14 days.  For estimation of clinical change, retest 
intervals should be ones during which a meaningful clinical change would have occurred (and from an intervention with known 
effectiveness). The evaluator decides overall whether this has sufficiently been addressed by the methods described.
1
No obvious sources of bias in the study test protocol or how tests were performed/administered is apparent; but there were 
suboptimal procedures or an inadequate description of the measurement protocol to be insured control of bias or that procedures 
were standardized. 
0 No description of the overall procedures for administering study tests; OR an obvious source of bias in data collection methods.
Analyses
9
2
Authors clearly defined which specific analyses were conducted for each of the stated specific hypotheses/questions of the study. 
This may be accomplished through organization of the results under specific subheadings or by demarcating which analyses 
addressed specific clinical measurement properties.  Data was presented for each hypothesis/research question posed.
1
Data was presented that addressed each of the measurement questions posed, but authors did not link specific analyses to specific 
research questions or hypotheses.
0 Data was not presented for every hypothesis or clinical measurement property outlined in the purposes or methods.
10
2
Tests selected - Appropriate statistical tests were conducted to calculate a point estimate for clinical measurement properties. 
Examples are provided below; but are not exhaustive.
1.  Reliability (Relative=ICCs for quantitative, Kappa for nominal data); absolute (SEM or plot of score differences vs. average score 
showing mean and 2 SD limit – as per Altman and Bland) 2.  Clinical relevance - minimal detectable change, clinically important 
difference 3.  Validity 
a. Validity associations - Pearson correlations for normally distributed data, Spearman rank correlations for ordinal data; or other 
correlations, if appropriate 
b. Validity tests of significant difference - an appropriate global test like analysis of variance was used where indicated, with post-hoc 
tests that adjusted for multiple testing
c. Validity of items scaling/responses - Rasch analysis or item response 4. Responsiveness- standardized response means or effect 
sizes or other recognized responsiveness indices were used.
1 Appropriate statistical tests were used in some instances; but suboptimal choices were made in other analyses. 
0 Inappropriate use of statistical tests - incorrect tests for type of data; or a lack of analysis
11
2
The study goes beyond a single statistical point estimate of a clinical measurement property and providing supporting statistical 
analyses that increases confidence in the findings in terms of precision of the (key) indicator; or provide an alternate form 
of analysis of the clinical measurement property. The evaluator decides if these analyses are appropriate and informative.  For 
example, with reliability, at least 2 of the following would constitute appropriate and informative analysis beyond a point estimate 
of a reliability coefficient: 1. confidence intervals around the point estimate; 2. Comparison to appropriate, referenced benchmarks 
or standards; or 3. SEM or MDC.  For correlations, tests of significance or confidence intervals were presented and indicators of 
the criterion benchmarks were provided.  For studies involving cross-cultural validation, the analyses should compare multiple 
clinical measurement properties previously established for the measure and explain the extent to which the translated version is in 
accordance with these previously reported properties on the source measure. 
1 Either precision definition (confidence intervals) or appropriate benchmark comparison were used - NOT both. OR Some analyses were associated with indicators of precision or alternate form of analysis -but not all key indicators.  
0 Inappropriate use of benchmarks or confidence intervals; or indicators of precision or alternate form are absent
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statistics-point estimates; 11) appropriate statistical 
precision-estimates; and 12) valid conclusions and 
recommendations. Each of the 12 criteria are graded 
using the following scheme: 0-point, if judged, ‘not 
done/documented’ OR ‘substantially inadequate’ OR 
‘inappropriate’; 1-point, if judged, ‘acceptable but 
suboptimal’; and 2-points, if judged, ‘consistent with 
best practice’. Any criteria deemed inapplicable to an 
article, is scored ‘NA’. The overall quality rating of an 
article is calculated by dividing the summed score of the 
evaluated criteria by the number of evaluated criteria 
in the article. The highest and lowest obtainable total 
quality score for an article, if all 12 criteria is assessed, 
is 24-points and 0-points respectively. An article’s total 
quality score can be converted to a percentage, which 
allows equilibrium across articles quality ratings; 
particularly, when some of the 12 criteria are deemed 
‘not applicable’ to an article. In this review, the quality 
percentage score of articles between 0%–30% will be 
marked as Poor, 31%–50% as Fair, 51%–70% as Good, 
71%–90% as Very Good, and > 90% as Excellent. The 
second review author (JCM), who is also the author of 
the structural critical appraisal tool, will be contacted to 
resolve any disagreements in that phase of the critical 
appraisal.
Phase 2: Assessment of Risk of Bias and Measurement 
Property Quality
The risk of bias and the quality of measurement 
properties accompanying individual study’s report on 
measurement properties will be assessed using the 
COSMIN risk of bias and quality criteria checklists (14, 
21-23). Regardless of individual authors definition of 
measurement properties, we will define all measurement 
properties according to the COSMIN consensus-based 
taxonomy of measurement properties (24). First, 
the articles will be assessed for risk of bias using the 
updated COSMIN risk of bias checklist, which has 10 
boxes that contains several items/questions scored 
on a 4-point rating scale as ‘very good’, ‘adequate’, 
‘doubtful’ and ‘inadequate’(21). The lowest rating for 
any item/question on a study’s measurement property 
determines its overall rating for methodological risk of 
bias. We will exclude two boxes (PROM development 
and content validity) of the ten boxes in the COSMIN 
risk of bias checklist because the BPI-SF and SF-MPQ-2 
were not originally developed for validation in MSK 
conditions (5, 6, 13).
Second, the quality of the articles will be assessed 
using the COSMIN quality criteria rating. All the 
extracted data on measurement properties for each of 
the tools in the included articles will be rated against 
the quality standard for measurement properties 
described in the COSMIN manual (also available 
at: https://www.cosmin.nl/) (14, 22, 23). Each 
measurement property (e.g. internal consistency, test-
retest reliability) will be rated as: “Sufficient” (+), if 
within the benchmark quality criteria; “Indeterminate” 
(?), if there was lacking report to contrast with the 
benchmark quality criteria, and; “Insufficient” (-), if 
the reported measurement property was below the 
benchmark quality criteria.
Planned Method of Analysis
The pooled mean values on statistical measurement 
properties evaluated in homogenous MSK populations 
using similar methodologies will be calculated. 
Results of correlations, Cronbach alphas (α), intraclass 
correlation coefficients (ICC), standardized response 
mean (SRM), standard error of measurement (SEM), 
effect sizes (ES), will be summarized using meta-
analysis. Forest plots will be used to estimate the 
level of heterogeneity. A sensitivity analysis will be 
performed on the measurement reports to compare the 
findings from studies with low risk of bias (‘very good’ 
to ‘adequate’ quality rating) with those with high risk of 
bias (‘doubtful’ to ‘inadequate’ quality ratings). We will 
then weigh the meta-analysis according to the study 
sample sizes. 
Studies with sample population or methodology 
Table 3. Continued
Recommendations
12
2
Authors made specific conclusions and clinical measurement recommendations that were clearly related to each hypotheses/
question posed in the study and that were supported by the data presented.  Ideal recommendations would state the estimated 
status of the clinical measurement property, the confidence in the estimate and the context for which those apply.  To achieve a 2, the 
conclusion must be specific; and conclusions cannot overstate the clinical measurement properties observed the study; nor ignore 
suboptimal measurement properties found.
1
Authors made conclusions and clinical measurement recommendations that were basically true (supported by study data); but 
vague. That is, they do not specify the extent, confidence or context of the findings.  (The measure is “reliable and valid ”) OR authors 
made specific clinical measurement recommendations; but for only some of the study hypotheses.
0
Authors did not make conclusions about clinical measurement; OR made recommendations that were in contradiction to the actual 
data presented
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heterogeneity will be assessed using narrative 
synthesis; tables will be used to summarize their 
findings. Our descriptions will include the MSK 
conditions evaluated with the tools (Mixed or 
Specific), the methodologies employed to assess 
both tools’ measurement properties, the findings on 
the measurement properties and the quality of the 
studies. In our synthesis, more attention will be given 
to the consistency of reports contained in studies 
rated sufficient (+), with low risk of bias (‘very good’ 
or ‘adequate’ quality rating). First, we will pool/
summarize the results extracted for the measurement 
properties per tool with emphasis placed on studies 
with low risk of bias (‘very good’ and/or ‘adequate’ 
quality ratings). The estimated intraclass correlation 
coefficient (ICC) for the BPI-SF and SF-MPQ-2 will be 
summarized using a weighted average. Cronbach’s 
alpha for internal consistency will be summarized 
using the observed range of occurrences while 
proportions of correlations supporting criterion-
convergence within the ‘low-to-moderate’ range 
(rho = 0.3-0.69), and ‘high’ range (rho ≥ 0.7) will be 
noted. For structural validity, responsiveness and 
known group validity, narrative synthesis will be used 
to summarize findings on both tools’ measurement 
properties. 
Evidence Synthesis
We will apply the COSMIN Modified GRADE approach, 
as described in the updated COSMIN manual to 
determine the level of evidence supporting the two 
questionnaires measurement properties (13). The 
COSMIN Modified GRADE approach considers the risk 
of bias, inconsistency, imprecision and indirectness 
associated with the pooled findings on each tool’s 
measurement properties. We will apply the COSMIN 
modified GRADE approach under the assumption 
that the MSK conditions studied holistically represent 
other MSK conditions, irrespective of their type 
(mixed or specific) (13, 21). Two reviews authors 
will independently conduct the quality assessment 
and evidence synthesis and then meet to synthesize 
their findings. If misunderstandings arise from their 
meeting, a third review author will be contacted.
Discussion
Musculoskeletal conditions encompasses a broad 
range of problems affecting the muscles, bones, 
soft tissue, and joints. Although 291 identified MSK 
conditions have been defined, and each present 
with a unique pain experience, generic pain 
assessment tools are sometimes assumed useful 
for pain assessment in these conditions (2). The 
BPI-SF and SF-MPI-2 are examples of commonly 
used multidimensional PROMs for pain evaluation 
in different types of MSK conditions in the clinical 
and research settings. However, a review that pools 
and translates measurement research findings on 
both PROMs psychometric properties has not been 
conducted. This gap in the literature leaves clinicians/
researchers with no choice than to make selection 
decisions based on their personal observation of face 
validity/appearance, ready availability/access to the 
tools, word of mouth/recommendation of colleagues, 
their observed use in other practice setting, and the 
suggestions contained in single studies.  A systematic 
synthesis of a group of single studies would provide 
information on the measurement properties of BPI-SF 
and SF-MPQ-2 in the broad-scope of MSK conditions; 
and this would provide a more reliable and evidence-
based rationale for selecting and using these tools in 
the clinic and research setting.  
In summary, our review protocol focuses on 
understanding the available evidence of the 
measurement properties of the BPI-SF and SF-MPQ-2 
in painful MSK conditions. The review will employ 
two comprehensive critical appraisal processes and 
yield synthesized evidence that will guide the choice of 
clinicians and researchers evaluating MSK conditions 
with the BPI-SF and SF-MPQ-2 in MSK conditions. 
Furthermore, our findings hope to identify the strengths 
and/or weaknesses of both tools and we hope to offer 
recommendations for future research either with or on 
the tools.
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APPENDIX 1.
Piloted search concepts, each for the BPI-SF and SF-MPQ-2, to be adapted on the following bibliographic databases: Medline CINAHL EMBASE and 
Scopus.
A. (“Brief Pain Inventory”) AND (Psychometric OR “Measurement Properties” OR Validation OR Adaptation OR “Cross-cultural” OR Reliability OR Validity 
OR “Internal Consistency” OR Sensitivity OR Specificity OR Discriminative OR Responsiveness OR “Factor analysis” OR Minimal Clinically Important 
Difference OR “Clinically Important difference” OR Rasch)
B. (“McGill Pain Questionnaire”) AND (Psychometric OR “Measurement Properties” OR Validation OR Adaptation OR “Cross-cultural” OR Reliability 
OR Validity OR “Internal Consistency” OR Sensitivity OR Specificity OR Discriminative OR Responsiveness OR “Factor analysis” OR Minimal Clinically 
Important Difference OR “Clinically Important difference” OR Rasch)
